Distinction of basal-like and triple-negative basallike breast cancers utilizing a novel comprehensive single-cell liquid biopsy-based test

被引：0
作者：
Cunsolo, Alessandra
Bourdon, David
Lam, Ernest
Di Caro, Giuseppe
Dharajiya, Nilesh
Pluard, Timothy
Schwartzberg, Lee
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-06-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-06-12
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype
    Peeter Karihtala
    Päivi Auvinen
    Saila Kauppila
    Kirsi-Maria Haapasaari
    Arja Jukkola-Vuorinen
    Ylermi Soini
    [J]. Breast Cancer Research and Treatment, 2013, 138 : 81 - 90
  • [32] Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype
    Karihtala, Peeter
    Auvinen, Paivi
    Kauppila, Saila
    Haapasaari, Kirsi-Maria
    Jukkola-Vuorinen, Arja
    Soini, Ylermi
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (01) : 81 - 90
  • [33] Inhibiting the Rho pathway in the triple-negative, basal-like breast cancer cell line, TMX2-28, inhibits invasive behavior
    Fagan-Solis, Katerina D.
    Smith-Schneider, Sallie
    Arcaro, Kathleen F.
    [J]. CANCER RESEARCH, 2011, 71
  • [34] A Novel Risk-Predictive Metric Stratifies Triple-Negative Breast Cancers Based on Cell Cycling Kinetics
    Klimov, Sergey
    Green, Andrew
    Aleskandarany, Mohammed A.
    Rakha, Emad
    Ellis, Ian O.
    Cantuaria, Guilherme
    Agboola, Ayodeji O.
    Reid, Michelle
    Li, Xiaoxian
    Rida, Padmashree C. G.
    Aneja, Ritu
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 51A - 51A
  • [35] A Novel Risk-Predictive Metric Stratifies Triple-Negative Breast Cancers Based on Cell Cycling Kinetics
    Klimov, Sergey
    Green, Andrew
    Aleskandarany, Mohammed A.
    Rakha, Emad
    Ellis, Ian O.
    Cantuaria, Guilherme
    Agboola, Ayodeji O.
    Reid, Michelle
    Li, Xiaoxian
    Rida, Padmashree C. G.
    Aneja, Ritu
    [J]. MODERN PATHOLOGY, 2016, 29 : 51A - 51A
  • [36] CYC065, a novel CDK2/9 inhibitor: Molecular basis for clinical development in basal-like triple-negative breast cancer
    Blake, D. G.
    MacKay, C.
    Frame, S.
    Zheleva, D.
    [J]. CANCER RESEARCH, 2016, 76
  • [37] Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers
    De Brot, Marina
    Rocha, Rafael M.
    Soares, Fernando A.
    Gobbi, Helene
    [J]. PATHOLOGY, 2012, 44 (04) : 303 - 312
  • [38] Androgen Receptor is Frequently Expressed by ER and HER2-Positive Breast Cancers but is Largely Restricted to Carcinomas with Apocrine Features among Triple-Negative/Basal-Like Breast Cancers Limiting its Predictive Value
    Thomason, Jon
    Dhungana, Neha
    Jensen, Kristin C.
    Bellizzi, Andrew
    [J]. MODERN PATHOLOGY, 2018, 31 : 109 - 109
  • [39] Androgen Receptor is Frequently Expressed by ER and HER2-Positive Breast Cancers but is Largely Restricted to Carcinomas with Apocrine Features among Triple-Negative/Basal-Like Breast Cancers Limiting its Predictive Value
    Thomason, Jon
    Dhungana, Neha
    Jensen, Kristin C.
    Bellizzi, Andrew
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 109 - 109
  • [40] Discovery of structure-based small molecular inhibitor of αB-crystallin against basal-like/triple-negative breast cancer development in vitro and in vivo
    Zhijuan Chen
    Qing Ruan
    Song Han
    Lei Xi
    Wenguo Jiang
    Huabei Jiang
    David A. Ostrov
    Jun Cai
    [J]. Breast Cancer Research and Treatment, 2014, 145 : 45 - 59
12345